Cited by 1Autism Spectrum Disorder ResearchGenetics and Neurodevelopmental DisordersBioinformatics and Genomic Networks

Systems-level multi-omics dissection of syndromic and idiopathic autism reveals distinct regulatory architectures, candidate molecular signatures, and potential therapeutic targets

Rudhra, Ondippili, Singh, Sanjeev Kumar·2026·Computers in Biology and Medicine

Abstract

Biological systems operate as self-organizing information networks in which genetic, epigenetic, and regulatory interactions collectively determine functional outcomes. Autism encompasses a heterogeneous set of neurodevelopmental conditions, including syndromic and idiopathic subtypes. Despite extensive gene discovery efforts, how these autism subtypes differ in their underlying organization of biological information remains poorly understood. Here, we apply an integrative systems-level, multi-omics framework to compare syndromic and idiopathic autism as distinct regulatory systems. High-confidence autism risk genes were curated from the SFARI and AutismKB databases, and analyzed using functional enrichment, protein-protein interaction network modeling, graph-theoretic hub identification, brain-region, cell-type-specific transcriptomic validation, experimentally supported miRNA regulatory network reconstruction, and deep learning-based drugtarget interaction analysis. Our analyses reveal clear differences in network organization between autism subtypes. Idiopathic autism is predominantly associated with synaptic signaling, ion channel activity, and transcriptional modulation, with hub genes KAT2B and AR enriched in basal ganglia-associated regions and astrocytes. In contrast, syndromic autism shows enrichment for transcriptional regulation, chromatin remodeling, and dense miRNA-mediated control, with hub genes CHD3 and CSNK2A1 preferentially expressed in cerebellar and cortic…

Integrity signals

Registry

Crossref · 10.1016/j.compbiomed.2026.111822

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Accumulating molecular evidence suggests that clinically defined subgroups may exhibit partially distinct patterns of genetic liability and molecular perturbation.

    “Although the syndromic versus non-syndromic distinction originated as an operational clinical classification rather than a strict biological dichotomy, accumulating molecular evidence suggests that these clinically defined subgroups may exhibit partially distinct patterns of genetic liability and molecular perturbation (Rudhra and Singh, 2026).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rudhra, O., & Singh, S. K.
Affiliations
Alagappa University (IN)
Corresponding author
Singh, Sanjeev Kumar
Venue
Computers in Biology and Medicine
Publisher
Elsevier BV
Published
2026-08
Volume
213
Pages
111822
ISSN
0010-4825 (ISSN-L)
OpenAlex
W7165522373
Cited by
1
References
67
Citations by year
2026: 1
FWCI
4.13
Type
journal article
Language
en
Open access
closed
Locations
  • Computers in Biology and Medicine (publishedVersion)
  • PubMed (publishedVersion)
Funders
Department of Science and Technology, Ministry of Science and Technology, India (DST/WOS-A/LS-434/2021)
Topics
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Autism Spectrum Disorder Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetics and Neurodevelopmental Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
Keywords
syndromic autism, idiopathic autism, autism heterogeneity, gene regulatory networks, miRNA regulatory network, hub genes, KAT2B, AR, CHD3, CSNK2A1, post-transcriptional regulation, synaptic signaling, ion channel activity, chromatin remodeling, therapeutic target discovery, drug-target interaction prediction, cell type-specific transcriptomics, protein-protein interaction network
MeSH terms
Multiomics, Autistic Disorder, Humans, MicroRNAs, Gene Regulatory Networks, Transcriptome, Protein Interaction Maps

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review